I

ITCI

Intra-Cellular Therapies

This stock has been delisted.

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Cash from Operating Activities

-73.18M

-124.20M

-270.19M

-259.54M

-230.07M

Net Income

-74.68M

-139.67M

-256.26M

-284.13M

-227.01M

Depreciation/Depletion & Amortization

508.00K

528.00K

656.00K

533.36K

528.12K

Deferred Taxes

--

--

0

0

264.61K

Non-Cash Items

55.09M

44.52M

43.55M

30.40M

23.68M

Changes in Working Capital

-54.10M

-29.58M

-58.14M

-6.35M

-27.54M

Cash from Investing Activities

-335.15M

105.54M

-128.37M

280.34M

-480.30M

Capital Expenditures

-322.00K

-269.00K

-778.00K

-325.74K

-266.72K

Other Investing Cash Flow Items, Total

-334.83M

105.81M

-127.59M

280.67M

-480.03M

Cash from Financing Activities

567.51M

17.81M

455.16M

11.52M

664.18M

Financing Cash Flow Items

--

--

--

--

--

Total Cash Dividends Paid

--

--

--

--

--

Issuance (Retirement) of Stock, Net

567.51M

17.81M

455.16M

11.52M

664.18M

Issuance (Retirement) of Debt, Net

--

--

--

--

--

Foreign Exchange Effects

--

--

--

--

--

Net Change in Cash

159.18M

-848.00K

56.60M

32.32M

-46.19M

Cash Interest Paid

--

--

--

--

--

Cash Taxes Paid

1.82M

162.00K

6.00K

5.63K

1.60K